Anti‐Ku alloimmunization due to a <i>KEL*02N.19</i> allele causing Kell‐null phenotype despite <i>KEL*02</i> genotype prediction
This case illustrates the importance of integrating serological, enzymatic and molecular approaches in the identification of antibodies to high-prevalence antigens and highlights alternative strategies to manage transfusion in complex oncology patients.
Authors
- RaviC Dara (ORCID: https://orcid.org/0000-0003-4686-7024)
- Kathleen M. Bensing
- Eiman AlZaabi (ORCID: https://orcid.org/0000-0002-0810-0888)
- Rania Madkour
- Ghada Mawad
- N. Chada
- Ihsanullah Sadiq
- Manuel Algora
Institutions
- Sheikh Shakhbout Medical City (AE)
- Versiti Blood Center of Wisconsin (US)
Publication Details
- Journal
- Vox Sanguinis
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1111/vox.70209
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00